Avantax Advisory Services’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,500
Closed -$35.5K 1659
2023
Q4
$35.5K Buy
+12,500
New +$35.5K ﹤0.01% 1550